Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Curr Oncol Rep ; 22(7): 65, 2020 06 08.
Artigo em Inglês | MEDLINE | ID: mdl-32514647

RESUMO

PURPOSE OF REVIEW: The review aims to summarize the present knowledge about cardiovascular toxicities associated with immune checkpoint inhibitors (ICI) and dissect underlying mechanism associated with individual cardiovascular toxicity. RECENT FINDINGS: Widespread use of ICI therapy has allowed for increasing recognition of a wide spectrum of immune-related adverse events that leave all organ systems vulnerable. Immune-mediated cardiovascular toxicities, initially thought to be rare, are more often being reported and present considerable challenges due to their non-specific clinical presentation, potential to have a fulminant progression, and overlap with other cardiovascular and general medical illnesses. Myocarditis is the most common manifestation of ICI-associated cardiovascular toxicity. Pericardial diseases, vasculitis, Takotsubo syndrome, conduction abnormalities, and destabilization of atherosclerotic lesions constitute other significant adverse events. At this stage, mechanisms underlying fundamental biology of cardiac toxicity have not been studied comprehensively and there remain gaps of knowledge in the current literature concerning the underlying pathomechanisms. It is hypothesized that immune-mediated myocarditis is a result of an exaggerated adaptive immune response against shared epitopes in the myocardium and tumor cells. Further, underlying mechanism of other cardiovascular toxicities is still unclear, further compounded by sparsity of epidemiological data. It is paramount to understand the mechanisms behind ICI-induced cardiovascular toxicities to develop appropriate treatment and prevention strategies and minimize the morbidity and mortality of cancer patients undergoing ICI therapy.


Assuntos
Doenças Cardiovasculares/induzido quimicamente , Inibidores de Checkpoint Imunológico/efeitos adversos , Síndrome Coronariana Aguda/induzido quimicamente , Arritmias Cardíacas/induzido quimicamente , Cardiotoxicidade/tratamento farmacológico , Humanos , Miocardite/induzido quimicamente , Cardiomiopatia de Takotsubo/induzido quimicamente
2.
Perit Dial Int ; 39(3): 289-291, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31088934

RESUMO

We herewith report 2 unusual cases of spontaneous peritoneal dialysis (PD) catheter fracture in intramural and intra-abdominal segments, respectively, in PD patients with long vintage. There were no associated infections or mechanical trauma. The patients presented with PD catheter outflow failure. Both the patients had their catheter replaced and resumed PD without any further issues. Probable causes and comparison with the reported cases are discussed.


Assuntos
Cateteres de Demora/efeitos adversos , Remoção de Dispositivo/métodos , Falha de Equipamento , Falência Renal Crônica/terapia , Diálise Peritoneal Ambulatorial Contínua/efeitos adversos , Cavidade Abdominal/crescimento & desenvolvimento , Cavidade Abdominal/cirurgia , Desenho de Equipamento , Feminino , Seguimentos , Humanos , Falência Renal Crônica/diagnóstico , Assistência de Longa Duração , Pessoa de Meia-Idade , Diálise Peritoneal Ambulatorial Contínua/instrumentação , Medição de Risco
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...